The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.
News briefing 1
When: Monday, November 2, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
- Four months hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patients (late-breaking study).
- Additional, specialized radiation not necessary for some women after mastectomy.
- Radiation after surgery reduces chance of melanoma returning.
- What are the real benefits versus risks of preventative brain radiation for patients with non-small cell lung cancer?
Where: McCormick Place West, Room 176b/c or on the Web at https://astro.webex.com/astro/j.php?ED=117037132&RG=1&UID=0&RT=MiM3
News briefing 2
When: Monday, November 2, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed:
- Stereotactic radiotherapy stops lung cancer from growing in frail patients.
- Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patients.
Where: McCormick Place West, Room 176b/c or on the Web at https://astro.webex.com/astro/j.php?ED=117046102&RG=1&UID=0&RT=MiM3
News briefing 3
When: Tuesday, November 3, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
What: News briefing with live webcast from ASTRO's 51st Annual Meeting.
Study findings previewed: